asianprimenews
Breaking NewsGeneralPublic Interest

Suraksha Diagnostic Limited: Initial public offering to open on Friday, November 29, 2024

(L-R): Mr. Viral shah, Executive Director & Head – ECM, Syndication, Nuvama Wealth Management Limited, Mr. Santosh Verma, Head – Healthcare & Pharma, ICICI Securities Limited, Dr. Somnath Chatterjee, Chairman and Joint Managing Director, Suraksha Diagnostic Limited, Ms. Ritu Mittal, Joint Managing Director and Chief Executive Officer, Suraksha Diagnostic Limited, and Mr. Ratnadeep Acharyya, Senior Vice President, SBI Capital Markets Limited addressing the gathering at the press conference in connection with Suraksha Diagnostic Limited’s forthcoming Initial Public Offering (IPO).

 

 

ASBA process.

 

 

 

The Equity Shares of the Company are proposed to be listed on BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”, together with BSE, the “Stock Exchanges”).

 

 

 

ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited are the Book Running Lead Managers (“BRLMs”) to the Offer.

 

 

 

Disclaimer:

 

SURAKSHA DIAGNOSTIC LIMITED is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to undertake an initial public offering of its Equity Shares and has filed the RHP with the RoC on November 25, 2024. The RHP shall be available on the website of SEBI at www.sebi.gov.in, on the websites of the Stock Exchanges i.e. BSE and NSE at www.bseindia.com and www.nseindia.com, respectively, on the website of the Company at www.surakshanet.com/investor-relations and the websites of the Book Running Lead Managers (“BRLMs”), i.e. ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited at www.icicisecurities.com, www.nuvama.com and www.sbicaps.com, respectively. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section entitled ‘Risk Factors’ on page 36 of the RHP. Potential investors should not rely on the DRHP filed with SEBI for making any investment decision.

 

 

 

This announcement has been prepared for publication in India and may not be released in the United States. This announcement does not constitute an offer of securities for sale in any jurisdiction, including the United States, and any securities described in this announcement may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended, or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the Company and that will contain detailed information about the Company and management, as well as financial statements. However, no offering of securities is being made in the United States.

Share

Related posts

She is unapologetic about voicing her opinions,” says Nitya Mathur on her character ‘Nikita’ in Amazon miniTV’s Sisterhood

asianprimenews

Immerse Yourself in Jasmine Modi’s 4-Day Spring Detox Program at Acushastra to Energize Your Mind, Body, and Soul

asianprimenews

Oakley Meta HSTN Set to Launch in India on December 1, with Performance-Driven AI Features

asianprimenews